A physician is reviewing data from a recent randomized, placebo-controlled clinical trial evaluating a novel oral therapeutic agent for the prevention of chronic kidney disease progression in high-risk patients. The trial followed two cohorts of patients over a 3-year period to assess both efficacy and safety. The physician is evaluating the net clinical benefit of the medication to prepare for a patient consultation.
The following raw data were reported at the end of the trial:
| Outcome | Novel Therapeutic Agent () | Placebo () |
|---|---|---|
| Primary outcome (disease progression) | events | events |
| Severe mycotic infection (adverse event) | events | events |
Applying conservative clinical epidemiological rounding principles, which of the following correctly pairs the Number Needed to Treat (NNT) to prevent one primary outcome with the Number Needed to Harm (NNH) for one severe mycotic infection?
- NNT: 15; NNH: 15Cevap
- BNNT: 14; NNH: 16
- CNNT: 15; NNH: 16
- DNNT: 14; NNH: 15
- ENNT: 13; NNH: 11
Cevap
NNT: 15; NNH: 15
The correct answer accurately calculates the Number Needed to Treat (NNT) and Number Needed to Harm (NNH) and correctly applies conservative clinical rounding principles. The ARR is , yielding an unrounded NNT of . To avoid overestimating clinical benefit, NNT is always rounded UP to the next whole integer (). The ARI is , yielding an unrounded NNH of . To avoid underestimating clinical risk, NNH is always rounded DOWN to the next whole integer ().
Adım Adım Çözüm
Anahtar Kavram
Calculation and conservative clinical rounding principles for Number Needed to Treat (NNT) and Number Needed to Harm (NNH).
Tahmini Süre:1m 30s